Sunteți pe pagina 1din 4

Daftar pustaka

1. PERKENI. Konsensus Pengendalian dan Pencegahan Diabetes Militus Tipe 2 di


Indonesia. Jakarta: PB PERKENI, 2011.
2. Ramachandran V, Saravanan R. Efficacy of asiatic acid, a pentacyclic triterpene on
attenuatting the key enzymes activities of carbohydrat metabolism in streptozotocininduced diabetic rats. Phytomedicine. 2013;20:230-6.
3. International diabetes federation (IDF). Diabetes atlas. 5th ed belgium; russels:2012.
4. Sirait M. ISO Indonesia. Jakarta: PT. ISFI Penerbitan, 2013 sept; 48:pp.385-7.
5. Redaksi Agromedia. 273 ramuan tradisional untuk mengatasi aneka penyakit. Jakarta:
PT Agro Media pustaka, 2008:pp.11-15.
6. Mantzoros c. Insuline resistance: definition and clinical spectrum. 2011; Up todate ver
19 (1).
7. Ali R, Athar M, Abdullal A, Abidi SA, Qayyum M. Nutraceuticals as natural healers:
Emerging evidences. Afri. J. Of biotehnol.2009;8(6):891-9.
8. Ammari F. Long-term complikations of diabetes militus in the western area of Saudi
Arabia. Diabetol Croat.2004;33-2.
9. Chandra A, Mahdi AA, Ahmad S, Singh RK. Indian herbal result in hypoglikemik
response in streptozotocin-induced diabetes rats. Nutr. Res. 2007;27:161-8.
10. Palsamy P,Subramanian S. Resveratol, a natural phytoalxin, normalizes hyperglikemia
in streptozotocin-nicotinamide induced experimental diabetik rats. Biomed &
pharmacothe.2008;62:598-605.
11. EL-Demerdash FM, Yousef MI, El-Naga NIA. Biochemical study on the
hypoglikemik effects of anion and garlic in alloxan-induced diabetik rats. Food and
chem. Toxicol.2005;43:57-63.
12. Rathi SK, DSouza P. Rational and ethical use of topical corticosteroids based on
safety and effi cacy. Indian J Dermatol. 2012; 57(4): 251-9.
13. Boediardja SA. Kortikosteroid topikal: Penggunaan yang tepat dalam praktek
dermatologi. Jakarta: Departemen Kulit dan Kelamin Fakultas Kedokteran
Universitas Indonesia. 2013. Hal.1- 14.
14. Ference JD, Last AR. Choosing topical corticosteroids. Am Fam. Physician 2009;
79(2): 135-40.
15. Oakley A. Topical corticosteroid treatment for skin conditions. A review. Specialist
Dermatologist and Clinical Associate Professor, Tristram Clinic, Hamilton.
16. Valencia IC, Kerdel FA. Topical corticosteroids. In: Wolff K, Goldsmith LA, Katz SI,
Gilchrest BA, Paller AS, Leff el DJ, eds. Fitzpatricks dermatology in general
medicine. 8th ed. New York: McGraw-Hill Co Inc; 2012. p. 2659-65.
17. Djuanda A. Pengobatan dengan kortikosteroid sistemik dalam bidang
dermatovenereologi. In: Djuanda A, ed. Ilmu penyakit kulit dan kelamin. 5th ed.
Jakarta: Fakultas Kedokteran Universitas Indonesia; 2007. p. 339-41.
18. Slamet susilo, 1992. Peran jamu dan obat tradisional dalam pelayanan kesehatan
masyarakat, Antropologi Kesehatan Indonesia Jilid I. Penerbit buku Kedokteran,
Jakarta.
19. Nordlie RC, Foster JD, Lange AJ.Regulation of glucose production by the liver.
Annual Rev nutrition. 1999; 19:379-406.

20. Soewondo P, Ferrario A,Tahapary DL. Challenges in diabetes management in


indonesia: a literature review. Globalization and Health. 2013;9:63.
21. Sari KI, Periadnadi, Nasir N. Uji antimikroba ekstrak segar jahe-jahean
(zingiberaceae) terhadap Staphylococcus aureus,escherichia coli dan candida
albicans. Jurnal biol Univ Andalas.2013:20-4.
22. Rahmadan AJ. Rimpang jahe untuk pengobatan. Yogyakarta: diandra
pustakaindonesia, 2013:pp. 2-8.
23. Skripsi kak putri
24. Dr skripsi kak putri hal 65
25. Suyono S. Patofisiologi Diabetes Militus dalam penatalaksanaan Diabetes Militus
Terpadu. Jakarta: Pusat Diabetes dan Lipid RSUP Nasional Dr. Cipto
Mangunkusumo/Fakultas Kedokteran Universitas Indonesia;2005.
26. Departemen Kesehatan RI. Diabetes militus ancaman umat manusia di dunia[online]
[cited 30 juli 2009] from
URL http://www.depkes.go.id/index.php?
option=news&task=viewarticle&sid=942&Itemid=2.
27. Trucco M. Regeneration of the pancreatic cell. J Clin Invest. 2005 January
3;115(1):5-12.
28. Departemen Kesehatan RI. Diabetes militus masalah kesehatan masyarakat yang
serius[online] [cited 30 juli 2009] from URL http://www.depkes.go.id/index.php?
option=news&task=viewarticle&sid=942&Itemid=2
29. Dari harper halaman 140
30. Mantzoros C. Insulin resistance: definition and clinical spectrum. 2011;UpTodate ver
19(1).
31. Goodman & Gilsmans manual of pharmacologic therapeutics. 11th ed. New York: Mc
Graw Hill;2008.
32. Stehouwer CDA, Schaper NC. Therapeutic strategies in Diabetic. 1th Ed. Oxford:
Clinical publishing; 2009.
33. Bailey CJ, Future Drug Treatment For Type 2 Dabetes. Textbook of Diabetes. 4th Ed.
London: Wiley Blackwell; 2010.P.1023-7.
34. Dr buku endokrin hal 80
35. Holt T, Kumar S. ABC of Diabetes. 6th Ed. London: Wiley-Blackwell;2010.
36. Soewondo P. Konsensus pengelolahan dan pencegahan dan pencegahan Diabetes
Militus tipe 2 di indonesia. Jakarta: PB PERKENI; 2011. hal: 1-14.
37. Powers AC. Diabetes Militus in Fauci, A.S.,et al. Harrisons Principles of internal
Medicine. 17th ed. New York: Mc Graw Hill medical; 2008.p. 2775-304.
38. Widya. Ekstraksi oleoresin dari jahe. Jur Teknol dan industri pangan. 2007;6(2): 1319.
39. BermawiN, Purwiyanti S. Botani, sistematika dan keanekaragaman kultivar jahe.
Artikel Teknol Hasil Penelitian Jahe. 2013:1-19. Diunduh dari
http://balittro.litbang.deptan.go.id
40. Hapsoh, Hasanah Y,`julianti E. Budidaya dan teknologi pasca panen jahe. Medan:
USU Press. 2008:2-10.
41. Astuti AD, Murbawani EA. Efektivitas pemberian ekstrak jahe merah (zingiber
officinale roscoe var rubrum) dalam mengurangi nyeri otot pada altlit sepak takraw.
Artikel penelitian Univ Diponegoro. 2011:7-16.

42. Hermani, Winarti C. Kandungan bahan aktif dan pemanfaatannya dalam bidang
kesehatan. Teknologi hasil penelitian jahe. Diunduh dari
http//balitrro.litbang.deptan.go.id./ind/images/publikasi/monograph/jahe/kandunganja
he. Pdf diunduh pada 2 februari 2014:pp.125-36.
43. Widianti R. Analisa kandungan fenol total jahe ( zingiber officinale roscoe). Jur Med
Research Indonesia Univ. 2009. 7-12.
44. Mashhadi NS, et al. Influence of ginger and cinnamon intake on
inflamation and muscle soreness endued by exercise in iranian
female athletes. Int J Prev Med. 2013; 4(1): 11-5. Diunduh dari
http://www.ncbi.nlm.gov/pmc/articles/PMC3665015/ pada 24 juli
2014.
45. Tripathi S, Bruch D, Kittur DS. Ginger extract inhibits LPS induced macrophage
activation and function. BMC Compenent Altern Med. 2008. Diunduh dari
http://www.biomedcentral.com/ pada 24 juli 2014
46. Utami P, Puspaningtyas DE. The miracle of herbs. Jakarta: Agromedia, 2013:pp.82-3
47. Tim Trubus. 100 plus herbal Indonesia, bukti ilmiah dan racikan. Jakarta: Trubus info
KIT, 2011:11:pp. 117-8.
48. Arief M. Ilmuh meracik obat. Yogyakarta: Gajah Madah University Press, 2010:pp.
165-8.
49. Syamsuni, H. A. Ilmuh resep. Jakarta: Penerbit Buku Kedokteran EGC, 2006:166-71.
50. Widya. Ekstraksi oleoresin dari jahe. Jur Teknol dan Industri Pangan. 2007;6(2): 1319.
51. Ansel HC. Pengantar bentuk sediaan farmasi. 4th ed. Jakarta: UI-Press, 2008:pp. 3907.
52. Dwiastuti R. Pengaruh penambahan CMC sebagai gelling agent dan propilen glikol
sebagai humektan dalam sediaan gel sunscren ekstrak kering polifenol teh hijau. Jur
Penelitian. 2010; 13(2):5-7.
53. Sembiring BS. Penanganan pengolahan rimpang jahe. Artikel Teknol Hasil penelitian
jahe. 2011:pp.113-6. Diunduh dari
http://balitro.litbang.deptan.go.id/ind/images/publikasi/monograph/jahe/penangananda
npengolahanrimpangjahe pada 10 maret 2014.
54. Anwar E. Eksipien dalam sediaan farmasi karakterisasi dan aplikasi. Jakarta: Dian
Rakyat, 2012:pp. 228-45.
55. Eleazu CO, Eleazu KC, Chukwuma S, Essien UN. Riview of the mechanism od cell
death resulting from streptozotocin challenge in experimental animals, its practical
use and potential risk to humans. J diab&Metab Disorder. 2013;12:60.
56. Lesen S. Alloxan and streptozotocin diabetes. Diabetologia. 2007;51:216-26.
57. Rakieten L, Rakieten ML, Nadkarni MV. Studies of the diabetogenic action of
streptozotocin. Cancer Chem Rep. 1963;29:91-8.
58. Elsner M, Guldbakke B, tiedge M, Munday R, Lenzen S. Relative importance of
transport and alkylation for pancreatic beta-cell toxicity of streptozotocin.
Diabetalogia. 2007;43:1528-33.
59. Valentovic MA, Alejandro N, Betts CA, Brown PI, ramos K. Streptozotocin (STZ)
diabetes enhances benzo(alpha)pyrene induced renal injury in Sprague Dawley rats.
Toxicol Lett. 2006; 164:214-20.

60. Vergani L, Floreani M, Russell A, Ceccon M, Napoli E, Cabrelle A, et al. Antioxidant


defences and homeostatis of reactive oxygen species in defferent human
mitochondrial DN-deplted cell lines. Eur J Biochem . 2004; 271: 3646-56.
61. Hunt JV, Smith CC, Wolff SP. Auto-okxidative glycosilation and possible
involvement of peroxides and free radicals in LDL modification by glocose. Diabetes.
1990;39:1420-4.
62. Matsuoka T,Kajimoto Y,Watada H, Kaneto H, Khisimoto M,Umayahara Y, et al.
Glycation-dependent reactive axygen species-mediated suppresion of the insulin gene
promoter activity in HIT cells. J Clin Invest. 1998;99:144-50.
63. Stauffacher W, Burr I, Gutzelt I, Beaven D, et al. Streptozotocin diabetes: time course
of irreversible -cell damage; further observations on prevention by nicotinamide.
Proc Soc Exp Biol Med. 1970;133:194-200.
64. Joo HL, Si HY, Jung Moh, Myung GL. Pharmocokinetics of drug in rats with diabetes
militus induced by alloxan or streptozotocin: comparison with those in patients with
type I diabetes militus. J pharm pharmacol. 2010;62: 1-23.
65.